Jacobson Pharma Corporation Limited (2633.HK)

HKD 1.25

(5.04%)

Net Income Summary of Jacobson Pharma Corporation Limited

  • Jacobson Pharma Corporation Limited's latest annual net income in 2023 was 266.96 Million HKD , up 6.34% from previous year.
  • Jacobson Pharma Corporation Limited's latest quarterly net income in 2023 FY was 266.96 Million HKD , up 6.34% from previous quarter.
  • Jacobson Pharma Corporation Limited reported an annual net income of 251.04 Million HKD in 2022, up 41.3% from previous year.
  • Jacobson Pharma Corporation Limited reported an annual net income of 177.66 Million HKD in 2021, up 2.28% from previous year.
  • Jacobson Pharma Corporation Limited reported a quarterly net income of 112.92 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a quarterly net income of 125.82 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Jacobson Pharma Corporation Limited (2023 - 2013)

Historical Annual Net Income of Jacobson Pharma Corporation Limited (2023 - 2013)

Year Net Income Net Income Growth
2023 266.96 Million HKD 6.34%
2022 251.04 Million HKD 41.3%
2021 177.66 Million HKD 2.28%
2020 173.71 Million HKD -19.44%
2019 215.63 Million HKD -13.94%
2018 250.56 Million HKD 23.87%
2017 202.27 Million HKD 12.79%
2016 179.32 Million HKD 23.16%
2015 145.61 Million HKD 42.89%
2014 101.9 Million HKD -40.88%
2013 172.35 Million HKD 0.0%

Peer Net Income Comparison of Jacobson Pharma Corporation Limited

Name Net Income Net Income Difference
Pak Fah Yeow International Limited 105.03 Million HKD -154.161%
Grand Pharmaceutical Group Limited 1.87 Billion HKD 85.8%
Extrawell Pharmaceutical Holdings Limited -162.94 Million HKD 263.835%
Wai Yuen Tong Medicine Holdings Limited -15.35 Million HKD 1838.526%
Qianhai Health Holdings Limited -52.7 Million HKD 606.533%
Lee's Pharmaceutical Holdings Limited 16.69 Million HKD -1498.802%
Essex Bio-Technology Limited 275.25 Million HKD 3.012%
Tongfang Kontafarma Holdings Limited -28.84 Million HKD 1025.59%
PuraPharm Corporation Limited -106.08 Million HKD 351.664%
SSY Group Limited 1.31 Billion HKD 79.754%
JBM (Healthcare) Limited 130.46 Million HKD -104.631%
China Resources Pharmaceutical Group Limited 3.85 Billion HKD 93.073%